Completed
Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
NCT00340080
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
- Locations
-
- GSK Investigational Site Darlinghurst, New South Wales, Australia
- GSK Investigational Site Miami, Queensland, Australia
- GSK Investigational Site Graz, Austria
- GSK Investigational Site Innsbruck, Austria